NEURO-EXERGAME: PILOT CLINICAL TRIAL OF AN IN-HOME INTERVENTION FOR MILD COGNITIVE IMPAIRMENT (IPACESV2.0)
Wall K, Stark J, Schillaci A, Saulnier E, McLaren E, Cohen B, Arciero P, Anderson-Hanley C. NEURO-EXERGAME: PILOT CLINICAL TRIAL OF AN IN-HOME INTERVENTION FOR MILD COGNITIVE IMPAIRMENT (IPACESV2.0). Innovation In Aging 2018, 2: 984-985. PMCID: PMC6239807, DOI: 10.1093/geroni/igy031.3642.Peer-Reviewed Original ResearchMild cognitive impairmentEnzyme-linked immunosorbent assayCognitive impairmentCognitive declinePilot clinical trialThree-month interventionExecutive functionTreat analysisDementia casesBiomarker levelsClinical trialsIGF-1Improved cognitionEfficacious interventionsPhysical exerciseSalivary biomarkersHome interventionSaliva samplesImmunosorbent assayCognitive outcomesWeek intervalsPilot dataBiomarkers and components of the interactive Physical and Cognitive Exercise System (iPACES™ v2.0) for Mild Cognitive Impairment (MCI): Cortisol, Dehydroepiandrosterone (DHEA‐S), and Insulin‐like Growth Factor (IGF1)
Wall K, Stark J, Karla‐Lall A, Schillaci A, Christian H, Doty C, McLaren E, Saulnier T, Cohen B, Anderson‐Hanley C. Biomarkers and components of the interactive Physical and Cognitive Exercise System (iPACES™ v2.0) for Mild Cognitive Impairment (MCI): Cortisol, Dehydroepiandrosterone (DHEA‐S), and Insulin‐like Growth Factor (IGF1). The FASEB Journal 2018, 32: 588.25-588.25. DOI: 10.1096/fasebj.2018.32.1_supplement.588.25.Peer-Reviewed Original ResearchMild cognitive impairmentCognitive outcomesCognitive impairmentSignificant cognitive improvementCognitive trainingCognitive interventionsCognitive abilitiesExecutive functionFlanker testCognitive improvementNeurobiological mechanismsSubjects designGame interventionCognitive declineOlder adultsEfficacious interventionsPrior researchStroopSuch interventions